Assessing survival time of heart failure patients: using Bayesian approach

Journal of Big Data - Tập 8 - Trang 1-18 - 2021
Tafese Ashine1, Geremew Muleta2, Kenenisa Tadesse2
1Department of Statistics, College of Natural Science, Assosa University, Assosa, Ethiopia
2Department of Statistics, College of Natural Science, Jimma University, Jimma, Ethiopia

Tóm tắt

Heart failure is a failure of the heart to pump blood with normal efficiency and a globally growing public health issue with a high death rate all over the world, including Ethiopia. The goal of this study was to identify factors affecting the survival time of heart failure patients. To achieve the aim, 409 heart failure patients were included in the study based on data taken from medical records of patients enrolled from January 2016 to January 2019 at Jimma University Medical Center, Jimma, Ethiopia. The Kaplan Meier plots and log-rank test were used for comparison of survival functions; the Cox-PH model and the Bayesian parametric survival models were used to analyze the survival time of heart failure patients using R-software. Integrated nested Laplace approximation methods have been applied. Out of the total heart failure patients in the study, 40.1% died, and 59.9% were censored. The estimated median survival time of patients was 31 months. Using model selection criteria, the Bayesian log-normal accelerated failure time model was found to be appropriate. The results of this model show that age, chronic kidney disease, diabetes mellitus, etiology of heart failure, hypertension, anemia, smoking cigarettes, and stages of heart failure all have a significant impact on the survival time of heart failure patients. The Bayesian log-normal accelerated failure time model described the survival time of heart failure patient's data-set well. The findings of this study suggested that the age group (49 to 65 years, and greater than or equal to 65 years); etiology of heart failure (rheumatic valvular heart disease, hypertensive heart disease, and other diseases); the presence of hypertension; the presence of anemia; the presence of chronic kidney disease; smokers; diabetes mellitus (type I, and type II); and stages of heart failure (II, III, and IV) shortened their survival time of heart failure patients.

Tài liệu tham khảo

Aalen O, Borgan O, Gjessing H. Survival and event history analysis: a process point of view. Berlin: Springer Science & Business Media; 2008.

Abebe TB, Gebreyohannes EA, Tefera YG, Abegaz TM. Patients with hfpef and hfref have different clinical characteristics but similar prognosis: a retrospective cohort study. BMC Cardiovasc Disord. 2016;16(1):232.

Adebayo SO, Olunuga TO, Durodola A, Ogah OS, et al. Heart failure: definition, classification, and pathophysiology–a mini-review. Nigerian J Cardiol. 2017;14(1):9.

Ahmad T, Munir A, Bhatti SH, Aftab M, Raza MA. Survival analysis of heart failure patients: a case study. PLoS ONE. 2017;12(7):e0181001.

Amare H, Hamza L, Asefa H. Malnutrition and associated factors among heart failure patients on follow-up at Jimma university specialized hospital, Ethiopia. BMC Cardiovasc Disord. 2015;15(1):128.

Akerkar R, Martino S, Rue H. Implementing approximate Bayesian inference for survival analysis using integrated nested Laplace approximations. Preprint Stat Norwegian Univ Sci Technol. 2010;1:1–38.

Avi E. Bayesian survival analysis: comparison of survival probability of hormone receptor status for breast cancer data. Int J Data Anal Tech Strategies. 2017;9(1):63–74.

Benjamin EJ, Muntner P, Bittencourt MS. Heart disease and stroke statistics 2019 update: a report from the American heart association. Circulation. 2019;139(10):e56–528.

Berger JO. Statistical decision theory and Bayesian analysis. Berlin: Springer Science & Business Media; 2013.

Bhattacharjee A. Application of Bayesian approach in cancer clinical trial. World J Oncol. 2014;5(3):109.

Brooks SP, Gelman A. General methods for monitoring convergence of iterative simulations. J Comput Graph Stat. 1998;7(4):434–55.

Chaloner K. Bayesian residual analysis in the presence of censoring. Biometrika. 1991;78(3):637–44.

Christensen R, Johnson W, Branscum A, Hanson TE. Bayesian ideas and data analysis: an introduction for scientists and statisticians. CRC Press; 2011.

Damasceno A, Mayosi BM, Sani M, Ogah OS, Mondo C, Ojji D, Dzudie A, Kouam CK, Suliman A, Schrueder N, et al. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries: results of the Sub-Saharan Africa survey of heart failure. Arch Intern Med. 2012;172(18):1386–94.

Depaoli S. The impact of inaccurate informative priors for growth parameters in Bayesian growth mixture modeling. Struct Equ Modeling. 2014;21(2):239–52.

Ganjali M, Baghfalaki T. Bayesian analysis of unemployment duration data in presence of right and interval censoring. JRSS. 2012;5(1):17–32.

Gelman A, Hwang J, Vehtari A. Understanding predictive information criteria for Bayesian models. Stat Comput. 2014;24(6):997–1016.

Giolo SR, Krieger JE, Mansur AJ, Pereira AC. Survival analysis of patients with heart failure: implications of time-varying regression effects in modeling mortality. PLoS ONE. 2012;7(6):e37392.

Habte B, Alemseged F, Tesfaye D. The pattern of cardiac diseases at the cardiac clinic of Jimma university specialised hospital, south west Ethiopia. Ethiop J Health Sci. 2010;20(2):99.

Hailay A, Kebede E, Mohammed K. Survival during treatment period of patients with severe heart failure admitted to intensive care unit (ICU) at Gondar university hospital (GUH), gondar, ethiopia. Am J Health Res. 2015;3(5):257–69.

Huffman MD, Berry JD, Ning H, Dyer AR, Garside DB, Cai X, Daviglus ML, Lloyd-Jones DM. Lifetime risk for heart failure among white and black Americans: cardiovascular lifetime risk pooling project. J Am College Cardiol. 2013;61(14):1510.

Ibrahim JG, Chen M-H, Sinha D. Bayesian survival analysis. Berlin: Springer Science & Business Media; 2001.

Ibrahim JG, Zhu H, Tang N. Bayesian local influence for survival models. Lifetime Data Anal. 2011;17(1):43–70.

Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53(282):457–81.

Khanal SP, Sreenivas V, Acharya SK. Accelerated failure time models: an application in the survival of acute liver failure patients in India. Int J Sci Res. 2014;3(6):161–6.

Klein JP, Moeschberger ML. Survival analysis: techniques for censored and truncated data. Berlin: Springer Science & Business Media; 2006.

Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48.

Martino S, Akerkar R, Rue H. Approximate Bayesian inference for survival models. Scand J Stat. 2011;38(3):514–28.

Misganaw A, Mariam DH, Ali A, Araya T. Epidemiology of major non-communicable diseases in Ethiopia: a systematic review. J Health Popul Nutr. 2014;32(1):1.

Miyagawa S, Pak K, Hikoso S, Ohtani T, Amiya E, Sakata Y, Ueda S, Takeuchi M, Komuro I, Sawa Y. Japan heart failure model derivation and accuracy of survival prediction in japanese heart failure patients. Circulation Rep. 2019;1(1):29–34.

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola V-P, Jankowska EA, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC). Developed with the special contribution of the heart failure association (HFA) of the esc. Eur J Heart Failure. 2016;18(8):891–975.

Qi J. Comparison of proportional hazards and accelerated failure time models. Ph. D. thesis; 2009.

Rue H, Martino S, Chopin N. Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations. J R Stat Soc Series b (Stat Methodology). 2009;71(2):319–92.

Sheng J, Qian X, Ruan T. Analysis of influencing factors on survival time of patients with heart failure. Open J Stat. 2018;8(04):651.

Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian approaches to clinical trials and health-care evaluation, vol. 13. Wiley; 2004.

Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, Charlson F, Davis A, Degenhardt L, Dicker D, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;386(9995):743–800.

Watanabe S. Asymptotic equivalence of Bayes cross validation and widely applicable information criterion in singular learning theory. J Mach Learn Res. 2010;11:3571–94.

Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, et al. 2013 accf/aha guideline for the management of heart failure: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. J Am Coll Cardiol. 2013;62(16):e147–239.

Zeru MA. Assessment of major causes of heart failure and its pharmacologic management among patients at Felege Hiwot referral hospital in Bahir dar, Ethiopia. J Public Health Epidemiol. 2018;10(9):326–33.

Thông tin
Thông tin xuất bản

Journal of Big Data

Tập 8

1-18

Thông tin tác giả